Unlocking the genomic and epigenetic variations that drive human health

About Us 

 

Nooma Bio is developing a proprietary dual-nanopore technology that enables scientists to unlock the genome-wide structural and epigenetic variations that drive human health. Our core platform produces ultra high-resolution genome and epigenome maps by performing repetitive electronic scans of oligo-tagged DNA molecules in a matter of seconds. We are privately held and headquartered in Santa Cruz, Calif.

 
Leadership Team
  • Kevin Corcoran, Chief Executive Officer
  • William Dunbar, PhD, Founder and Chief Technology Officer
  • Paul Lundquist, PhD, Senior Vice President of Engineering
  • Adrian Fehr, PhD, Vice President of Product Development